Michael S. Orr

3.0k total citations
24 papers, 683 citations indexed

About

Michael S. Orr is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael S. Orr has authored 24 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Michael S. Orr's work include DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer-related Molecular Pathways (5 papers). Michael S. Orr is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer-related Molecular Pathways (5 papers). Michael S. Orr collaborates with scholars based in United States, Canada and China. Michael S. Orr's co-authors include David A. Gewirtz, Frank A. Fornari, Joyce K. Randolph, W. David Jarvis, Lijia Yu, P M O'Connor, Steven Grant, Sharon E. Straus, Rosella Silvestrini and L. Orlandi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Nature Biotechnology.

In The Last Decade

Michael S. Orr

24 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S. Orr United States	14	402	237	101	80	46	24	683
Ahmed Chenna United States	17	434 1.1×	243 1.0×	110 1.1×	200 2.5×	110 2.4×	45	852
Shinsuke Homma Japan	11	582 1.4×	90 0.4×	128 1.3×	88 1.1×	54 1.2×	29	949
Marzena Kamińska Poland	10	187 0.5×	278 1.2×	34 0.3×	151 1.9×	11 0.2×	20	683
Yinyun Ni China	11	243 0.6×	143 0.6×	44 0.4×	143 1.8×	9 0.2×	22	646
Jaak Janssens Belgium	10	133 0.3×	97 0.4×	70 0.7×	56 0.7×	9 0.2×	18	510
Young Min Ahn South Korea	14	565 1.4×	112 0.5×	99 1.0×	89 1.1×	24 0.5×	26	817
I S Fentiman United Kingdom	17	157 0.4×	479 2.0×	31 0.3×	286 3.6×	14 0.3×	37	1.0k
Jolanta Smok-Kalwat Poland	14	132 0.3×	129 0.5×	65 0.6×	49 0.6×	14 0.3×	35	474
Athena Starlard‐Davenport United States	17	554 1.4×	211 0.9×	46 0.5×	265 3.3×	15 0.3×	55	1.0k
Zhuogang Liu China	17	480 1.2×	145 0.6×	35 0.3×	191 2.4×	8 0.2×	61	831

Countries citing papers authored by Michael S. Orr

Since Specialization

Citations

This map shows the geographic impact of Michael S. Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Orr more than expected).

Fields of papers citing papers by Michael S. Orr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Orr. The network helps show where Michael S. Orr may publish in the future.

Co-authorship network of co-authors of Michael S. Orr

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Orr. A scholar is included among the top collaborators of Michael S. Orr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Orr. Michael S. Orr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armstrong, Lucas C., Glenn E. Kirsch, Nikolai B. Fedorov, et al.. (2017). High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors. SLAS DISCOVERY. 22(6). 686–695. 5 indexed citations

Kirsch, Glenn E., Nikolai B. Fedorov, Yuri A. Kuryshev, et al.. (2016). Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors. Assay and Drug Development Technologies. 14(6). 333–344. 13 indexed citations

Shu, Mao, Hui Wen Ng, Michael S. Orr, et al.. (2016). Homology Model and Ligand Binding Interactions of the Extracellular Domain of the Human <i>α</i>4<i>β</i>2 Nicotinic Acetylcholine Receptor. Journal of Biomedical Science and Engineering. 9(1). 41–100. 5 indexed citations

Orr, Michael S.. (2014). Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future: Table 1. Tobacco Control. 23(suppl 2). ii18–ii22. 86 indexed citations

Mattes, William B., Xi Yang, Michael S. Orr, Patricia Richter, & Donna L. Mendrick. (2014). Biomarkers of Tobacco Smoke Exposure. Advances in clinical chemistry. 67. 1–45. 37 indexed citations

Laupacis, Andreas, et al.. (2012). Systematic review and evaluation of web-accessible tools for management of diabetes and related cardiovascular risk factors by patients and healthcare providers. Journal of the American Medical Informatics Association. 19(4). 514–522. 47 indexed citations

Orr, Michael S., et al.. (2007). The Experience with Voluntary Genomic Data Submissions at the FDA and a Vision for the Future of the Voluntary Data Submission Program. Clinical Pharmacology & Therapeutics. 81(2). 294–297. 22 indexed citations

Tong, Weida, Anne Bergstrom Lucas, Richard Shippy, et al.. (2006). Evaluation of external RNA controls for the assessment of microarray performance. Nature Biotechnology. 24(9). 1132–1139. 69 indexed citations

Orr, Michael S.. (2006). Toxicogenomics and Cross-Species Biomarker Discovery: Applications in Drug Discovery and Safety Assessment. Toxicology Mechanisms and Methods. 16(2-3). 79–87. 4 indexed citations

10.

Orr, Michael S., John L. Cleveland, Carlos Rodríguez‐Galindo, et al.. (2001). Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells33Abbreviations: ODC, ornithine decarboxylase; VM-26 (teniposide), 4′-demethylepipodophyllotoxin-4-(4,6-O-thenylidene-β-d-glucopyranoside); pRb, retinoblastoma protein; m-AMSA, amsacrine; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; and FBS, fetal bovine serum.. Biochemical Pharmacology. 62(5). 593–602. 18 indexed citations

11.

Orr, Michael S.. (2000). Effects of c-erbB2 Overexpression on the Drug Sensitivities of Normal Human Mammary Epithelial Cells. JNCI Journal of the National Cancer Institute. 92(12). 987–994. 28 indexed citations

12.

Orr, Michael S., William C. Reinhold, Lijia Yu, Nicole Schreiber‐Agus, & P M O'Connor. (1998). An Important Role for the Retinoblastoma Protein in Staurosporine-induced G1 Arrest in Murine Embryonic Fibroblasts. Journal of Biological Chemistry. 273(7). 3803–3807. 17 indexed citations

13.

Yu, Lijia, L. Orlandi, Pei Wang, et al.. (1998). UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase. Journal of Biological Chemistry. 273(50). 33455–33464. 87 indexed citations

14.

Fornari, Frank A., et al.. (1998). Induction of DNA Damage, Inhibition of DNA Synthesis, and Suppression of c-myc Expression by the Topoisomerase I Inhibitor, Camptothecin, in MCF-7 Human Breast Tumor Cells. Biochemical Pharmacology. 55(8). 1263–1269. 13 indexed citations

15.

Gewirtz, David A., et al.. (1998). Induction of DNA damage, inhibition of DNA synthesis and suppression of c- myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line. Cancer Chemotherapy and Pharmacology. 41(5). 361–369. 24 indexed citations

16.

Orr, Michael S., et al.. (1997). Ionizing Radiation and Teniposide Increase p21waf1/cip1 and Promote Rb Dephosphorylation but Fail to Suppress E2F Activity in MCF-7 Breast Tumor Cells. Molecular Pharmacology. 52(3). 373–379. 11 indexed citations

17.

Jarvis, W. David, et al.. (1996). Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death. International Journal of Radiation Biology. 69(2). 183–192. 9 indexed citations

18.

Fornari, Frank A., W. David Jarvis, Steven Grant, et al.. (1996). Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin. Biochemical Pharmacology. 51(7). 931–940. 63 indexed citations

19.

Orr, Michael S., Frank A. Fornari, Joyce K. Randolph, & David A. Gewirtz. (1995). Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase 11 inhibitor, VM-26. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1262(2-3). 139–145. 7 indexed citations

20.

Bunch, Roderick T., Lawrence F. Povirk, Michael S. Orr, et al.. (1994). Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells. Biochemical Pharmacology. 47(2). 317–329. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact